Views & Analysis A new approach to COVID-19 treatment While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr.
News US is planning $500m project on 'universal vaccines;' WSJ The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
